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1. Introduction
Severe fever with thrombocytopenia syndrome virus (SFTSV) is
a newly identiﬁed novel Phlebovirus of the Bunyaviridae family,1
which has been implicated as the causative agent of severe fever
with thrombocytopenia syndrome (SFTS) in China.2 The clinical
symptoms of SFTS are non-speciﬁc and include high fever,
gastrointestinal symptoms, thrombocytopenia, leukocytopenia,
multi-organ dysfunction, and hemorrhagic tendency.1 Most
reported SFTS cases have involved hospitalized patients with
relatively serious clinical symptoms, with an average case-fatality
rate of 12%.3 Fatal cases of infection with SFTSV have recently been
reported in South Korea and Japan as well.4,5 Haemaphysalis
longicornis ticks have been implicated as the vectors of SFTSV, and a
high seroprevalence of SFTSV has been reported in domestic
animals.1
The ﬁrst human case of SFTS in a rural area of Long County in
Shaanxi Province led to a seroprevalence study in the same village
where the ﬁrst case was detected, with the goal of estimating the
seroprevalence of SFTSV in this population.
2. Methods
2.1. Sample and data collection
We conducted a seroprevalence study in the village in Long
County where the ﬁrst case of SFTS was detected. A total of
363 serum samples were collected from 363 healthy volunteers. A
standardized questionnaire was used to collect information on
demographic characteristics including age, gender, and residential
address. The sampled population was divided into ﬁve age groups:
0–6, 7–19, 20–39, 40–59, and 60 years.
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Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease
discovered in China in 2009. In July 2013, the ﬁrst human infection with SFTS virus (SFTSV) was detected
in Shaanxi Province, Western China.
Methods: A seroprevalence study among humans was carried out in an SFTS endemic village;
speciﬁcally, serum samples were collected from 363 farmers in an SFTS endemic village in Shaanxi
Province. The presence of SFTSV antibodies in serum was determined using an ELISA.
Results: SFTSV antibodies were found in a total of 20 people (5.51%), with no signiﬁcant difference
between males and females (6.93% and 4.42%, respectively; Chi-square = 1.29, p = 0.25). Moreover, the
SFTSV antibody positive rate was not signiﬁcantly different across different age groups (Chi-
square = 2.23, p = 0.69).
Conclusions: SFTSV readily infects humans with outdoor exposure. The results of the serological study
indicate that the virus circulates widely in Shaanxi Province. SFTSV represents a public health threat in
China.
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Long County is located in Central China (Figure 1) and had a
population of a quarter million at the end of 2010. It has an annual
average temperature of 8–16 8C, and the average rainfall is
600 mm.
2.2. Serological testing
Samples were tested for the presence of SFTSV RNA by
quantitative real-time reverse transcription PCR (RT-PCR). Anti-
bodies (including IgG and IgM) in serum samples were detected
using a double-antigen sandwich ELISA, as described previously.6
Positive samples were further diluted to determine the antibody
titers.
2.3. Case deﬁnition
The patient was diagnosed based on the diagnosis and
treatment programs for severe fever with thrombocytopenia
syndrome issued by the Chinese Ministry of Health. The clinical
features include abrupt onset of fever (38 8C) and respiratory
tract or gastrointestinal symptoms, followed by a progressive
decline in platelets and white blood cells. A conﬁrmed case of SFTS
was deﬁned as a person who met these criteria and who also had at
least one of the following laboratory criteria for diagnosis: (1)
detection of SFTSV RNA by a molecular method, (2) seroconversion
or a 4-fold rise in antibody titers between two serum samples
collected at least 2 weeks apart, and (3) SFTSV isolated from clinical
specimens.
2.4. Statistical analyses
All statistical analyses were performed using SPSS 17.0 (SPSS
Inc., Chicago, IL, USA); the statistical signiﬁcance level was set at
0.05. The Chi-square test or Fisher’s exact test was used to assess
differences in SFTSV seroprevalence by gender and age group.
3. Results
The ﬁrst human case of SFTS in Shaanxi Province was a 66-year-
old man who had a sudden onset of fever on July 11, 2013, with a
temperature of 38 8C, accompanied by chills, pharyngeal pain,
nausea, vomiting, and abdominal pain. The patient’s family is
located in a rural area of Long County. The patient did not have a
history of outdoor activities before illness onset, and the patient’s
cattle had reportedly not been out of the village for the last 3 years.
Of the 363 volunteer participants, 173 (47.6%) were male and
190 (54.9%) were female. The ages of the participants ranged from
3 years to 80 years, and the median age was 42 years. A total of
363 serum samples were obtained from the healthy volunteers and
sent to the laboratory of Shaanxi Provincial Center for Disease
Figure 1. Location of Baoji in China and the location of selected districts where serum samples of healthy persons were collected and tested in 2013.
Table 1
Seropositivity for SFTSV among healthy humans in Shaanxi, China
Number of serum
samples tested
Number SFTSV-IgG
seropositive
Percentage
seropositive
Chi-square p-Value
Gender 1.29 0.25
Male 173 12 6.93
Female 190 8 4.42
Age, years 2.24 0.69
6 59 1 1.69
7–19 54 3 5.56
20–39 68 4 5.88
40–59 128 9 7.03
60 54 3 5.56
Total 363 20 5.51
SFTSV, severe fever with thrombocytopenia syndrome virus.
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Control and Prevention (CDC). Overall, 6% (20/363) of serum
samples were seropositive for SFTSV (6.93% among males and
4.21% among females). There was no statistically signiﬁcant
difference in seroprevalence between males and females (Chi-
square = 1.29, p = 0.25) (Table 1).
The sampled population was divided into ﬁve age groups (0–6,
7–19, 20–39, 40–59, and 60 years) and the corresponding
seroprevalence levels were 1.69% (1/59), 5.56% (3/54), 5.88% (4/
68), 7.03% (9/128), and 5.56% (3/54), respectively. Statistical
analyses showed that the seroprevalence of antibodies against the
virus did not increase with age (Table 1). None of the seropositive
participants reported any of the disease symptoms that are
associated with SFTSV infections.
4. Discussion
We found an SFTSV seroprevalence level of 5.51% in an SFTS
endemic village, which is similar to that reported in Hubei Province
(6.37%) and Zhejiang Province (5.51%), but much higher than that
reported in Shandong Province (0.84%) and Jiangsu Province
(0.94%).7–9 This discrepancy may be attributed to the season of
sample collection, age and sex of the subjects, previous exposure or
low level of infection, or differences in detection methods
employed in different studies. Furthermore, the seropositive
volunteers in our study had not had contact with the ﬁrst reported
patient before onset, which suggests that other infections in the
village may have resulted from natural exposure to a reservoir.
There was no statistical difference observed by sex, indicating
that men and women in rural areas of Shaanxi are equally exposed
to SFTSV; this is in line with the results of a prior study conducted
in Jiangsu Province, China in 2011.10 However, surveillance data
from 2012 and 2013 in Jiangsu Province have indicated that SFTSV
antibodies are more prevalent in males than in females.11 Further
studies are needed to clarify this difference.
Our study demonstrated that seroprevalence varied with age.
Speciﬁcally, there were signiﬁcant differences among studied age
groups for SFTSV infection. The incidence rate of SFTS was higher in
patients between 20 and 60 years of age compared to patients aged
<20 years. This suggests that the older age groups have
participated in long-term outdoor activities more than the other
age groups. However, the seroprevalence of SFTSV in healthy
people was not signiﬁcantly different among age groups in
Shandong Province, although SFTS patients were mainly elderly.12
In conclusion, our study indicates signiﬁcant levels of SFTSV
antibodies among healthy humans, which suggests subclinical
SFTSV infections or a relatively mild form of SFTS illness. More
emphasis is needed on this novel disease, including enhanced
surveillance activities related to the virus in ticks and domestic
animals.
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